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Abstract
Benzonaphthoxanthenones are a class of flavanoids which are absent in the
liverworts and hornworts and present only in the mosses. Ohioensins are
benzonaphthoxanthenones which are isolated from various moss species. First
compound of this series was isolated from the Polytrichum ohioense Renauld &
Cardot. and hence named as Ohioensin A. Together with Ohioensin A, there are 10
other Ohioensins (B–H) and their derivatives have been extracted from different
species of mosses. These compounds are pharmaceutically very important and
various studies have shown their usefulness as antioxidant, in Atherosclerosis and
cytotoxic activities against various human tumor cell lines. In this chapter, synthesis
of Ohioensins, their structure and potential medicinal uses are discussed.
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1. Introduction
Bryophytes are tinny nonvascular plants on the earth. They are classified into
three phyla Bryophyta (mosses), Marchantiophyta (liverworts) and Anthocer-
otophyta (hornworts) and represented by 14,000, 6000 and 300 species respec-
tively. Various compounds have been isolated from different species of bryophytes
which show antifungal, antiviral, antibacterial, allergic contact dermatitis, anti-
HIV, plant growth regulatory, cytotoxic, insecticidal, nitric oxide (NO) production,
superoxide anion radical release inhibitory, neurotrophic, muscle relaxing,
antiobesity, piscicidal, and nematocidal activities [1].
Among the bryophytes liverworts species possess cellular oil bodies. These are
single unit membrane-bound cell organelles that contain ethereal terpenoids and
aromatic oils suspended in proteinaceous matrix. Oil bodies are useful in taxonomy
and chemosystematics of the liverworts. However, their origin, development and
function in the plant is poorly understood. More than 1000 secondary metabolites
have been reported from oil bodies and which are considered to be useful in
medicine and various other activities. However, these organelles have not been
reported in the species of mosses and hornworts [1, 2]. Due to absence of the oil
bodies mosses possess comparatively less secondary metabolites. Though, various
compounds: monoterpenoids, diterpenoids, triterpenoids, steroids, carotenoids,
aromatic compounds (cinnamic acid, benzoic acid, flavones, isoflavones,
biflavones, aurones, anthocyanins, benzonaphthoxanthenones) and their
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derivatives, alkanes and related compounds, fatty acids (propionic, butylic, valeric,
caproic, isovaleric, phenylacetic, cyclohexanecarboxylic acid, palmitic acid,
eicosatetraenoic acid and octadecadienoic acid etc.), plant hormones (isopentenyl)
adenine (2iP), indole acetic acid) pheophytins and phytochelatins have been iso-
lated from different species of the mosses [3].
Flavonoids are common aromatic compounds present in the mosses and nearly
73 flavonoids and their glycosides have been isolated from different moss species
[1]. Benzonaphthoxanthenones are a class of flavanoids only present in the mosses
and have been isolated from various moss species [4]. Among Ohioensins,
Ohioensin A was first compound isolated from the Polytrichum ohioense Renauld &
Cardot. and hence named as Ohioensin A [5].
2. Ohioensins
Ohioensins compounds are isolated from various moss species. Chemical for-
mula and source of the compounds are summarized in Table 1 and their structures
are mentioned in Figure 1.
3. Synthesis of Ohioensins
Zheng et al. [6] proposed synthesis pathway of Ohioensins. They suggested that
these compounds are synthesized from the condensation of o-hydroxycinnamate
and hydroxylated bibenzyls. Their synthetic pathway is summarized in Figure 2.
S.
No.
Compound Formula Source References
1 Ohioensin A C23H16O5 Polytrichum ohioense Renauld & Cardot. [5, 6]
2 Ohioensin B C24H18O5 Polytrichum ohioense Renauld & Cardot. [6]
3 Ohioensin C C23H16O5 Polytrichum ohioense Renauld & Cardot. [6]
4. Ohioensin D C24H18O6 Polytrichum ohioense Renauld & Cardot. [6]
5. Ohioensin E C25H20O6 Polytrichum ohioense Renauld & Cardot. [6]
6. Ohioensin F C23H16O6 Polytrichastrum alpinum (Hedw.) G.L.
Sm.
[7]
7. Ohioensin G C23H16O6 Polytrichastrum alpinum (Hedw.) G.L.
Sm.
[7]
8. Ohioensin H C23H16O5 Polytrichum commune Hedw. [8]
9. 1-O-Methylohioensin B C25H20O5 Polytrichum pallidiserum Funck [9]
10. 1-O-
Methyldihydroohioensin B
C25H22O5 Polytrichum pallidiserum Funck [9]
11. 1,14-Di-O-
Methyldihydroohioensin
B
C26H24O5 Polytrichum pallidiserum Funck [9]
Table 1.
Source and formula of Ohioensins and their derivatives.
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Figure 1.
Structure of Ohioensins and their derivatives.
Figure 2.
Synthesis of Ohioensins.
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4. Pharmaceutical properties
4.1 Cytotoxic activity
Compounds extracted from different species of bryophytes have shown cyto-
toxic activity against various cancer cell lines as: P-388 murine leukemia tumor,
squamous carcinoma (KB), lung carcinoma (A549), breast ductal carcinoma
(MDA-MB-435), liver hepatoblastoma (HEP-G2), and colon adenocarcinoma
(LOVO) cell lines, glioma A172 cells, U87 glioma, T98G, osteosarcoma U2OS, leu-
kemia HL-60, K562, MDR K562/A02 and MCF-7 breast cancer etc. These com-
pounds induce apoptosis and necrosis through activation of caspases (a family of
cysteine aspartic proteases), DNA fragmentation, activation of p38 (mitogen-
activated protein kinase), nuclear condensation, proteolysis of poly (ADP-ribose)
polymerase (PARP) and inhibition of antiapoptotic nuclear transcriptional factor-
kappa B, etc. These mechanisms play important role in the maintenance of the cell
population size and apoptosis of cell in vivo [10]. Ohioensins also show cytotoxic
activities against various cancer lines.
• Ohioensin A exhibits cytotoxicity against murine leukemia (PS) cell line and
breast cancer cell line (MCF-7) in culture at ED50 (Effective Dose) 1.0 and
9.0 pg./mL, respectively [5].
• Ohioensin B show inhibitory activity against Mouse leukemia (9PS) [11]
Ohioensin B also show cytotoxic activity against MCF-7 human breast
adenocarcinoma, HT-29, human colon adenocarcinoma [6].
• Ohioensin C, Ohioensin D and Ohioensin E show activities against 9PS, murine
P388 leukemia [6].
• 1-O-methylohoensin B show activity against HT-29, human colon
adenocarcinoma, human melanoma RPMI-7951 and mild activity against
human glioblastoma multiforme U-251 MG [9].
• l-O-methyldihydroohioensin B inhibit human glioblastoma multiforme U-251
MG and 1,14-di-O-methyldihydroohioensin B inhibit human lung carcinoma
A549 and human melanoma RPMI-7951 cell lines [9].
• Ohioensin H exhibit cytotoxic activities against human T cell leukemia (6 T-
CEM), human lung carcinoma (A549), human bowel carcinoma (LOVO),
human breast adenocarcinoma (MDA-MB-435) and human hepatoma
carcinoma (HepG2) in concentration dependent manner [8].
4.2 Protein inhibitory activity
Ohioensin A (IC50 4.3 0.3 μM), Ohioensin C (IC50 7.6 0.7 l μM), Ohioensin F
(IC50 3.5  0.2 μM), Ohioensin G (IC50 5.6  0.7 μM) compounds inhibits the
activity of Protein tyrosine phosphatase 1B (PTP1B) in a dose-dependent manner [7].
4.3 In the treatment of atherosclerosis
Atherosclerosis disease is characterized by the disrupted balance and abnormal
accumulation of lipids, inflammatory cells, matrix deposits and smooth muscle cell
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proliferation in the wall of medium- and large caliber arteries [12]. Arteries are
composed of an outer layer (also known as adventitia), a tunica media (made up of
layers of smooth muscle cells) and interior layer (also called tunica intima) lined
with endothelium. During normal conditions balance between the concentrations of
nitrogen oxide (NO, act as vasodilator), and Endothelin-1 (ET-1, act as vasocon-
strictor) in the arteries is maintained and the endothelium is shielded from inflam-
mation, injury and thrombosis. Moreover, in such conditions leukocytes could not
bind to the endothelium, smooth muscle cells (SMCs) not proliferate and platelet
aggregation is minimized. However, during atherosclerosis NO production is
inhibited and protection conferred on the endothelial cells is removed [13]. Subse-
quently endothelium is exposed to leukocytes and SMCs begins to proliferate.
Excessive fat in the diet or genetic disorders cause increase in cholesterol and
saturated fat in the blood. The low density lipoprotein (LDL) assembles on the
proteoglycan of the endothelium and bind together to form aggregates. LDL
become highly susceptible for chemical modification and oxidation after aggrega-
tion. Oxidation is usually brought by lipoxygenases of infiltrating leukocytes
(monocytes and T-lymphocytes), NADH/NADPH oxidases of vascular cells.
Procoagulant properties are increased and anticoagulant properties are inhibited
when LDL oxidized. Oxidized LDL also increase adhesiveness of leukocyte to the
endothelium. When atherosclerosis set in endothelium expresses intercellular
adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and
P-selectins as leukocyte adhesion molecules. Furthermore, tumor necrosis factor α
(TNF-α) a cytokine, induces expression of ICAM-1 and VCAM-1 on vascular cells
[14]. Hence for curing the atherosclerosis, expression of ICAM-1 and VCAM-1
needs to be down regulate or block for inhibiting interaction between leukocytes
and vascular cells [15].
Ohioensin F, prevents TNF-α-stimulated expression of VCAM-1 and ICAM-1
and subsequently reduces monocyte adhesion to Vascular smooth muscle cells
(VSMCs). Effects of Ohioensin F also suppress ROS production, MAPK pathways,
Nuclear factor-κB (NF-κB) and Protein kinase B (Akt) activation. Thus, Ohioensin
F inhibits expression of adhesion molecules which may provide a new therapeutic
strategy for the treatment of atherosclerosis [16]. This property of the compound
already has been patented [17].
4.4 Antioxidant activity
Ohioensin F and Ohioensin G isolated from the methanolic extract of
Polytrichum alpinum showed potent antiradical activities against 2,20-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid (ABTS•+) and 2,2-Diphenyl-1-(2,4,6-
trinitrophenyl)hydrazyl (DPPH) free radicals. The compounds (ohioensin F and
ohioensin G) and the crude methanolic extract converted DPPH into DPPH-H by
donating a hydrogen atom and inhibited the production of the chromogen cation of
ABTS. Ohioensin F, ohioensin G and methanolic extract showed Fe3+ to Fe2+ reduc-
ing capacity and also show moderate activity against free radical nitric oxide (NO)
in dose-dependent manner [18].
5. Conclusions
Nearly all Ohioensins show cytotoxic activities against various cell lines, thus
these can be used in the treatment of the various Cancer. Though, more research is
needed in this aspect of the Ohioensins. Ohioensin F play important role in the
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treatment of atherosclerosis and act as strong antioxidant. However, further inves-
tigation for therapeutic potential of these compounds is warranted.
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